Literature DB >> 16390903

How should remission from depression be defined? The depressed patient's perspective.

Mark Zimmerman1, Joseph B McGlinchey, Michael A Posternak, Michael Friedman, Naureen Attiullah, Daniela Boerescu.   

Abstract

OBJECTIVE: Although experts in the treatment of depression have suggested that achieving remission is the primary goal of treatment, questions remain about how remission should be defined. In antidepressant efficacy trials, remission is defined according to scores on symptom severity scales. Normalization of functioning is often mentioned as an important component of remission, although it is not used to identify patients with remission in treatment studies. The authors' goal was to determine what depressed patients consider important in defining remission from depression.
METHOD: A brief questionnaire was distributed to 535 psychiatric outpatients who were being treated for DSM-IV major depressive episode. They were asked to rate the importance of 16 statements in determining whether depression is in remission.
RESULTS: The three items most frequently judged to be very important in determining remission were the presence of features of positive mental health such as optimism and self-confidence; a return to one's usual, normal self; and a return to usual level of functioning. The patients endorsed a statement about absence of symptoms with nearly similar frequency.
CONCLUSIONS: Patients aspire to a range of outcomes from the treatment of their depression.

Entities:  

Mesh:

Year:  2006        PMID: 16390903     DOI: 10.1176/appi.ajp.163.1.148

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  97 in total

1.  The Session Report Form (SRF): are clinicians addressing concerns reported by youth and caregivers?

Authors:  Susan Douglas Kelley; Ana Regina Vides de Andrade; Leonard Bickman; Ashley V Robin
Journal:  Adm Policy Ment Health       Date:  2012-03

2.  Optimal Well-Being after Major Depression.

Authors:  Jonathan Rottenberg; Andrew R Devendorf; Vanessa Panaite; David J Disabato; Todd B Kashdan
Journal:  Clin Psychol Sci       Date:  2019-02-08

3.  Improving study design for antidepressant effectiveness assessment.

Authors:  Florian Naudet; Bruno Millet; Jean Michel Reymann; Bruno Falissard
Journal:  Int J Methods Psychiatr Res       Date:  2013-08-30       Impact factor: 4.035

4.  Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up.

Authors:  W W IsHak; J Mirocha; D James; G Tobia; J Vilhauer; H Fakhry; S Pi; E Hanson; R Nashawati; E D Peselow; R M Cohen
Journal:  Acta Psychiatr Scand       Date:  2014-06-23       Impact factor: 6.392

5.  The Neurodynamics of Affect in the Laboratory Predicts Persistence of Real-World Emotional Responses.

Authors:  Aaron S Heller; Andrew S Fox; Erik K Wing; Kaitlyn M McQuisition; Nathan J Vack; Richard J Davidson
Journal:  J Neurosci       Date:  2015-07-22       Impact factor: 6.167

6.  STAR*D and Measurement-Based Care for Depression: Don't Toss Out the Baby!

Authors:  Raymond W Lam; Sidney H Kennedy
Journal:  Can J Psychiatry       Date:  2015-01       Impact factor: 4.356

7.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

Review 8.  The role of dopaminergic agents in improving quality of life in major depressive disorder.

Authors:  Waguih William IsHak; Michael Davis; Jessica Jeffrey; Konstantin Balayan; Robert N Pechnick; Kara Bagot; Mark Hyman Rapaport
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

9.  Clinical validity of a population database definition of remission in patients with major depression.

Authors:  Antoni Sicras-Mainar; Milagrosa Blanca-Tamayo; Laura Gutiérrez-Nicuesa; Jordi Salvatella-Pasant; Ruth Navarro-Artieda
Journal:  BMC Public Health       Date:  2010-02-11       Impact factor: 3.295

10.  Reliability and validity of the Japanese version of the Resilience Scale and its short version.

Authors:  Daisuke Nishi; Ritei Uehara; Maki Kondo; Yutaka Matsuoka
Journal:  BMC Res Notes       Date:  2010-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.